| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | 0.0036 | 0.9 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | -0.0026 | 0.9 |
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | -0.0024 | 1 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | -0.0022 | 1 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | 0.0027 | 1 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | -0.0022 | 1 |
| mRNA | Dasatinib | FIMM | pan-cancer | AAC | 0.0085 | 1 |
| mRNA | Bryostatin 1 | GDSC1000 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | AZD0530 | FIMM | pan-cancer | AAC | 0.008 | 1 |